What are the Benefits of the EVO ICL^TM?

< Back to FAQ

The EVO ICL™ offers a number of benefits to consider when deciding which vision correction procedure is right for you including:

1. Sharp, clear vision ¹
2. Excellent night vision ²
3. Does not usually cause dry eye syndrome ³
4. Short surgery recovery times
5. Does not remove corneal tissue
6. Removable by your doctor
7. Built in protection from UV rays.

 

Because the lens is implanted within the eye, it usually does not suffer from the same potential for displacement, movement, or discomfort as contact lenses on the surface of the eye. This means that patients can enjoy stable, long-term vision correction without the need for frequent adjustments or replacements.

The EVO ICL offers sharp clear vision3 during the day and also at night^4-6.

Another advantage of the EVO ICL™ is its biocompatibility. The collamer material used in the lens is well-tolerated by the body, reducing the risk of inflammation, infection, or other complications following surgery. The EVO ICL™ also preserves the cornea, which can be particularly beneficial for patients with thin corneas or those who may not be good candidates for LASIK.

The lens also includes a built-in UV filter, helping to protect the eyes from damage caused by the sun's rays. Patients who choose the EVO ICL™ can enjoy improved vision, greater comfort, and low risk of complications.

At Clearview Eye and Laser Medical Center in San Diego, California, Dr. Sandy T. Feldman is dedicated to helping patients achieve optimal vision. Contact us today to learn more about the benefits of the EVO ICL™ and schedule a free evaluation to determine whether this may be the right option for you.

1.Igarashi A, Kamiya K, Shimizu K, Komatsu M. Visual Performance after implantable Collamer lens implantation and wavefront-guided laser in situ keratomileusis for high myopia. Am J Opthalmol. 2009
2. Martinez-Plazs E, Lopez-Miguel A, Lopez-De La Rosa A, et al. Effect of the EVO+ Visian Phakic Implantable Collamer Lens on Visual Performance and Quality of Vision and Life, Am J Ophthalmol 2021;226: 117-125
3. Ganesh S, Brar S, Pawar A. Matched population comparison of visual outcomes and patient satisfaction between 3 modalities for the correction of low to moderate myopic astigmatism. Clin Ophthalmol. 2017 Jul 3;11:1253-1263.
4. Schallhorn S, Tanzer D, Sanders DR, Sanders M, Brown M, Kaupp SE. Night driving simulation in a randomized prospective comparison of Visian toric implantable collamer lens and conventional PRK for moderate to high myopic astigmatism. J Refract Surg. 2010 May;26(5):321-6.
5. Takashi Kojima, Yoshihiro Kitazawa, Tomoaki Nakamura, Masahide Takahashi, Kazutaka Kamiya, Kazuo Ichikawa, Akihito Igarashi , Kimiya Shimizu. Prospective Randomized Multicenter Comparison of the Clinical Outcomes of V4c and V5 Implantable Collamer Lenses: A Contralateral Eye Study. J Ophthalmology. 2018 Sep 5;2018:7623829.
6. Parkhurst GD. A prospective comparison of phakic collamer lenses and wavefront-optimized laser-assisted in situ keratomileusis for correction of myopia. Clin Ophthalmol. 2016 Jun 29;10:1209-15.